Back to trial details

Intake questionnaire

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Applying to M D Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Stage III Lung Cancer AJCC v8?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Houston for study visits?